ACE and COVID-19: Polymorphism studies in countries that have a high COVID-19 prevalence showed that the insertion allele of the ACE deletion/insertion (D/I) polymorphism correlates with COVID-19 prevalence although the ACE enzyme has no direct impact on the SARS-CoV-2 pathogenesis.